Vardaan Biotech IPO

Initial public issue of upto 53,18,000 equity shares of face value of Rs. 10/- each (Equity Shares) of Vardaan Biotech Limited (VBL or the Company) at an issue price of Rs. [] per equity share (including a share premium of Rs. [] per equity share) for cash, aggregating up to Rs. [] crores (Public Issue) comprising a fresh issue of upto 48,18,000 equity shares aggregating to Rs. [] crores (the Fresh Issue) and an offer for sale of upto 5,00,000 equity shares by Lokendra Singh Rajput; (The Selling Shareholders) aggregating to [] equity shares by the selling shareholders (Offer for Sale) aggregating to Rs. [] crores out of which 5,32,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [] per equity share for cash, aggregating Rs. [] crores will be reserved for subscription by the market maker to the issue (the Market Maker Reservation Portion). The public isssue less market maker reservation portion i.e. issue of [] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [] per equity share for cash, aggregating up to Rs. [] crores is hereinafter referred to as the Net Issue. The public isssue and net issue will constitute []% and [*]% respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.